Outcomes of infliximab dose escalation in patients with rheumatoid arthritis

Overview of attention for article published in Clinical Rheumatology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

than two infliximab escalations may be unwarranted in RA

Medical Health News, 17 May 2019

medwireNews: The clinical benefit of infliximab dose escalation in people with rheumatoid arthritis (RA) may be limited to the…

More than two infliximab escalations may be unwarranted in RA

medwireNews, 17 May 2019

medwireNews: The clinical benefit of infliximab dose escalation in people with rheumatoid arthritis (RA) may be limited to the…